✦ LIBER ✦

Fingolimod: an oral disease-modifying therapy for relapsing multiple sclerosis

✍ Scribed by E. Ann Yeh; B. Weinstock-Guttman

Publisher: Springer Healthcare Communications
Year: 2011
Tongue: English
Weight: 514 KB
Volume: 28
Category: Article
ISSN: 0741-238X
DOI: 10.1007/s12325-011-0004-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Disease-modifying therapies for multiple

Disease-modifying therapies for multiple sclerosis

✍ John R. Corboy; Douglas S. Goodin; Elliot M. Frohman 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 657 KB

Oral Disease-Modifying Therapies for Mul

Oral Disease-Modifying Therapies for Multiple Sclerosis: Are We There Yet?

✍ Vijayshree Yadav; Dennis Bourdette 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 71 KB

15-Deoxyspergualin (15-DOS) for therapy

15-Deoxyspergualin (15-DOS) for therapy in an animal model of multiple sclerosis (MS): Disease modifying activity on acute and chronic relapsing experimental allergic encephalomyelitis (EAE)

✍ H. U. Schorlemmer; F. R. Seiler 📂 Article 📅 1991 🏛 SP Birkhäuser Verlag Basel 🌐 English ⚖ 330 KB

Innate origins of multiple sclerosis pat

Innate origins of multiple sclerosis pathogenesis: Implications for computer-assisted design of disease-modifying therapies

✍ Nicholas Stoy 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 519 KB

## Abstract The rational development of disease‐modifying therapies for multiple sclerosis (MS) requires a detailed knowledge of disease pathogenesis, but this remains incomplete. Dynamic computer‐assisted modeling of MS is currently hindered by uncertainties about the connectivity, compartmentaliz